课题基金 / 基金详情

Development study of preventive and therapeutic drugs for Alzheimertype senile dementia by using biologically active peptides

Development study of preventive and therapeutic drugs for Alzheimertype senile dementia by using biologically active peptides
生物活性肽预防和治疗阿尔茨海默型老年痴呆药物的开发研究
批准号:
07672396
负责人:
UKAI Makoto
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

UKAI Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
1. P物质对东莨菪碱诱导的自发交替性能损伤的影响(1)P物质改善了东莨菪碱诱导的自发交替性能损伤。(2)速激肽NK-1受体拮抗剂WIN62577.2可拮抗P物质的改善作用。tyr - d - arg - ph - β - ala - nh_2 (TAPA)对被动回避学习的影响(1)TAPA对被动回避学习有抑制作用。(2)用mu-阿片受体拮抗剂-funaltrexamine治疗可以逆转TAPA的损伤作用。甘丙肽对被动回避学习、提升+迷宫学习和自发交替表现的影响(1)甘丙肽对被动回避学习有抑制作用,但对提升+迷宫学习和自发交替表现无影响。全身注射dynorphin A-(1-13)对环己亚胺所致被动回避学习障碍的影响(1)腹腔注射dynorphin A-(1-13)对环己亚胺所致被动回避学习障碍的影响。(2)卡帕-阿片受体拮抗剂-甲萘托非明可逆转dynorphin A-(1-13)的改善作用。δ -阿片受体激动剂对学习和记忆的影响(1)[D-Pen^2, L-Pen^5]脑啡肽和[D-Ala^2] δ啡肽II抑制被动回避学习,尽管它们不影响自发交替表现或提高+迷宫学习。这些结果表明,选择性阿片受体和δ阿片受体的阿片肽和丙氨酸可引起健忘症,而P物质和运动啡具有抗健忘症的作用。此外,它可能是一种促智神经肽。
英文摘要
1. Effects of substance P on scopolamine-induced impairment of spontaneous alternation performance(1) Substance P improved the scopolamine-induced impairment of spontaneous alternation performance.(2) The improving effects of substance P were antagonized by treatment with the tachykinin NK-1 receptor antagonist WIN62577.2. Effects of Tyr-D-Arg-Phe-beta-Ala-NH_2 (TAPA) on passive avoidance learning(1) TAPA inhibited passive avoidance learning.(2) The impairing effects of TAPA were reversed by treatment with mu-opioid receptor antagonist beta-funaltrexamine.3. Effects of galanin on passive avoidance learning, elevated plus-maze learning and spontaneous alternation performance(1) Galanin inhibited passive avoidance learning, although it had no effects on elevated plusmaze learning or spontaneous alternation performance.4. Effects of systemic administration of dynorphin A-(1-13) on cycloheximide-induced impairment of passive avoidance learning(1) The intraperitoneal injection of dynorphin A-(1-13) impaired the cycloheximide-induced impairment of passive avoidance learning.(2) The improving effects of dynorphin A-(1-13) were reversed by treatment with the kappa-opioid receptor antagonist nor-binaltorphimine.5. Effects of delta-opioid receptor agonists on learning and memory(1) [D-Pen^2, L-Pen^5] enkephalin and [D-Ala^2] deltorphin II inhibited passive avoidance learning, although they did not affect spontaneous alternation performance or elevated plus-maze learning.These results suggest that opioid peptides selective for mu-and delta-opioid receptors and galanin evoke anmesia, while substance P and dynorphin possess anti-amnesic effects. Moreover, it is possible that dynorphin is one of the nootropic neuropeptides.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Makoto Ukai: "Effects of the k-opioid dynorphin A-(1-13) on learning and memory in mice." Behavioral Brain Research. (印刷中). (1997)
Makoto Ukai:“k-阿片类强啡肽 A-(1-13) 对小鼠学习和记忆的影响”(正在出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
MAkoto Ukai, Norihiro Shinkai and Tsutomu Kameyama: "Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice." Japanese Journal of Psychopharmacology. 16. 97-101 (1996)
MAkoto Ukai、Norihiro Shinkai 和 Tsutomu Kameyama:“神经激肽 A 和senktide 可减轻东莨菪碱引起的小鼠自发交替行为损伤。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Makoto Ukai, Tetsuya Kobayashi, Kaori Mori, Norihiro Shinkai, Yusuke Sasaki and Tsutomu Kameyama: "Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH_2, a novel dermorphin analog with high affinity for mu-opioid receptors." European Journal of Pharmacol
Makoto Ukai、Tetsuya Kobayashi、Kaori Mori、Norihiro Shinkai、Yusuke Sasaki 和 Tsutomu Kameyama:“Tyr-D-Arg-Phe-beta-Ala-NH_2 可以减弱记忆力,这是一种对 mu-阿片受体具有高亲和力的新型皮吗啡类似物。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Development of novel therapeutic drugs for Alzheimer disease
    • 批准号:
      14572081
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2002
    • 负责人:
      UKAI Makoto
    • 依托单位:
    Developmental study on anti-dementia drugs by using neuropeptides related to memory disturbance
    • 批准号:
      11672197
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      UKAI Makoto
    • 依托单位:
    Establishment of Animal Models of Dementia with Neuropeptides and Development Study of Anti-Dementia Drugs
    • 批准号:
      09672261
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.02万
    • 财政年份:
      1997
    • 负责人:
      UKAI Makoto
    • 依托单位:
    国内基金
    海外基金
    新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
    • 批准号:
      81000622
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2010
    • 负责人:
      梁胜
    • 依托单位:
    阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
    • 批准号:
      31060293
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2010
    • 负责人:
      郭亚芬
    • 依托单位:
    跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究